My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-140
CBCC
>
Official Documents
>
2020's
>
2023
>
2023-140
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/4/2023 12:08:17 PM
Creation date
8/4/2023 12:06:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
07/11/2023
Control Number
2023-140
Agenda Item Number
8.T.
Entity Name
RxBenefits. Inc. f/k/a Prescription Benefits, Inc
Subject
Addendum to Administrative Service Agreement reflecting improved pricing
and updates effective January1, 2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
23
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5332467E-CBEF-4C5D-8BOE-61 E380BDAl 1 B <br />DocuSign Envelope ID: 151 EGOGF-855C-414F-9455-72004347A310 <br />(112023 Version) <br />• Indian River County Board of County <br />No Charge (Elected) <br />Commissioners Clinical -All Plans -Remove <br />MCAP SaveOnSP fee <br />• Low Clinical Value Exclusions (LCV) <br />Elected <br />Indian River County Board of County <br />$0.30 per claim <br />Commissioners Clinical -All Plans - <br />Remove MCAP SaveOnSP fee <br />• High Dollar Claim Review (HDCR) <br />Elected <br />c Indian River County Board of County <br />$0,95 per claim <br />Commissioners Clinical -All Plans - <br />Remove MCAP SaveOnSP fee <br />Initial Determinations (i.e. coverage reviews) and Level <br />Included in the existiniz utilization <br />One Non -Urgent Appeals under the UM program. <br />management PMPM charge <br />Examples: Prior Authorization. Step Therapy, Drug <br />OR <br />Quantity Management <br />Included in the existing PA charge of $55 per <br />initial determination* <br />OR <br />No Charge if Client elects HDCR <br />Initial Determinations and Level One Non -Urgent Appeals <br />$55 per initial determination <br />for benefit reviews. Examples: copay review, plan <br />OR <br />excluded drug coverage review, administrative plan design <br />No Charge if Client elects HDCR <br />review. <br />Final Internal Appeals Level Two Appeals and/or Urgent <br />S 10 per review* <br />Appeals for UM, formulary, and benefit reviews. <br />OR <br />No Charge if Client elects HDCR <br />External Reviews by Independent Review Organizations -for <br />$800 per review <br />non -grandfathered plans <br />OR <br />Miscellaneous <br />No Ch -g- if Client elects HDCR <br />Third Party Integration Fees <br />Charges passed through from provider or <br />mutually agreed upon by Parties <br />The following terms and conditions apply only if client does not elect HDCR: <br />■ Initial determination this is the first review of drug coverage based on the Plan's conditions of <br />coverage. Initial determinations are also referred to as initial reviews. coverage reviews, prior <br />authorization reviews, UM reviews, or benefit reviews. <br />■ The Level 2 and Urgent Appeal Service is an optional service for Clients to enroll in and there is <br />an incremental fee of $10 per initial detemlination. <br />• Level 2 and Urgent Appeals are not included in the UM package fees. <br />■ The Level 2 and Urgent Appeal Service fee is not charged per appeal. It is charged for each initial <br />review. This allows Client to better estimate their appeal costs since it is based on the number of <br />initial determinations. The fees cover the legal and operational costs involved with handling final <br />and binding appeal reviews, which includes, but is not limited to the following: staffing ofclinical <br />professionals and supportive personnel. notifications to patients and prescribers. and maintaining <br />a process aligned with state and federal regulations. <br />• Charges for the Level 2 and Urgent Appeal Service are billed on the monthly admin invoice for <br />completed initial determination for UM, formulary, and benefit reviews. No subsequent charges <br />are incurred when cases are appealed. <br />■ Appeals can be deemed urgent at Level I or Level 2. Urgent appeal decisions are final and <br />binding. If a Level I Appeal is processed as urgent. there is no Level 2 appeal. <br />NOT FOR DISTRIBUTION. TIIE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL„ PROPRIE"I'ARN' <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.